Gene · 427
Papers1,873
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,873
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic targeting of ASAH1 in combination with carnosine as a therapeutic strategy for TNBC. | Mol Metab | 2026 | 42815573 | PubTator, text mining | PubMed |
| Lipid tail length dictates membrane disruption by carmofur analogs and reveals noncanonical modes of action. | RSC Adv | 2026 | 42807973 | PubTator, text mining | PubMed |
| Porphyromonas gingivalis-Derived Phosphoglycerol-isoC17:0-Dihydroceramide Reprograms Sphingolipid Metabolism in Human OECM-1 Oral Squamous Cell Carcinoma Cells. | FASEB Bioadv | 2026 | 42781096 | PubTator, text mining | PubMed |
| Sphingolipid metabolism contributes to sex dimorphism in COPD pathogenesis. | JCI Insight | 2026 | 42771472 | PubTator, text mining | PubMed |
| Dysregulation of Sphingolipid Metabolism in Non-Obstructive Azoospermia: Insights from Bioinformatics and a Busulfan-Induced Mouse Model. | Reprod Sci | 2026 | 42722974 | PubTator, text mining | PubMed |
| Fluorogenic Tissue-Based Assessment of Acid Ceramidase Activity. | Bio Protoc | 2026 | 42656824 | PubTator, text mining | PubMed |
| Therapeutic Effects of Ceranib-2 and Irinotecan Combination on Colon Cancer. | Curr Issues Mol Biol | 2026 | 42651839 | PubTator, text mining | PubMed |
| A 3D human retina model reveals a non-cell-autonomous and non-neuronal mechanism of photoreceptor loss in a lysosomal storage disorder. | Sci Transl Med | 2026 | 42647598 | PubTator, text mining | PubMed |
| ZMAT3 alleviates cell death in Fanconi anemia via adaptation of sphingolipid metabolism. | Sci Adv | 2026 | 42536749 | PubTator, text mining | PubMed |
| Keeping it acid ceramidase: How adiponectin protects in the glomerulus. | J Pharmacol Exp Ther | 2026 | 42509125 | PubTator, text mining | PubMed |
| Multiomic profiling of responses to clinical and novel bisphosphonates reveals extraskeletal effects on ageing related signatures. | Signal Transduct Target Ther | 2026 | 42448670 | PubTator, text mining | PubMed |
| Acid ceramidase modulates the lipid profile and exacerbates sensitivity to ferroptosis in WI-38 replicative senescent cells. | Cell Death Dis | 2026 | 42431858 | PubTator, text mining | PubMed |
| A human lysosomal storage disorder toolkit for decoding proteome landscapes in cortical-like and dopaminergic-like induced neurons. | Proc Natl Acad Sci U S A | 2026 | 42384675 | PubTator, text mining | PubMed |
| An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidates. | bioRxiv | 2026 | 42244548 | PubTator, text mining | PubMed |
| PSAP Protects Against Acute Myocardial Ischemia-Reperfusion Injury by Promoting ASAH1-Mediated Ceramide Metabolism. | J Cardiovasc Transl Res | 2026 | 42234286 | PubTator, text mining | PubMed |
| Death following high-dose AAV9 gene therapy in a patient with advanced SMA-PME. | Mol Ther | 2026 | 42198847 | PubTator, text mining | PubMed |
| xNNPCD identifies regulators of programmed cell death by integrating perturbation transcriptomes with cancer dependency profiles. | bioRxiv | 2026 | 42182318 | PubTator, text mining | PubMed |
| Farber Lipogranulomatosis With Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy: Expanding the Phenotypic Spectrum. | J Child Neurol | 2026 | 42175818 | PubTator, text mining | PubMed |
| Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia. | Blood Neoplasia | 2026 | 41994327 | PubTator, text mining | PubMed |
| Intersection of Spinal Muscular Atrophy and Progressive Myoclonic Epilepsy Syndrome: ASAH1 Gene. | Ann Indian Acad Neurol | 2026 | 41964139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/427/papers